Insider Trading March 5, 2026

Vicor Director Sells $250K in Shares, Exercises Options the Same Day

Shen Zheng John disposes of direct holdings while exercising non-qualified options as Vicor shares trade near their 52-week high

By Hana Yamamoto VICR
Vicor Director Sells $250K in Shares, Exercises Options the Same Day
VICR

Director Shen Zheng John sold 1,217 shares of Vicor CORP (NASDAQ:VICR) on March 4, 2026, for $205.75 per share, generating proceeds of $250,397 and leaving him with no direct holdings. On the same day he exercised Non Qualified Stock Options to acquire 1,217 shares at $32.89, valued at $40,027. Vicor's shares have climbed 233% over the past year and were trading at $187.88, close to a 52-week high of $209.53. InvestingPro flags the stock as appearing overvalued at a P/E of 73 and lists 19 additional ProTips for investors.

Key Points

  • Director Shen Zheng John sold 1,217 Vicor shares on March 4, 2026, for $205.75 per share, totaling $250,397, and now holds no shares directly.
  • On the same day Shen exercised Non Qualified Stock Options to acquire 1,217 shares at $32.89, valued at $40,027.
  • Vicor shares have climbed 233% over the past year, trading at $187.88 and close to a 52-week high of $209.53; InvestingPro reports a P/E of 73 and provides 19 ProTips for investors.

Director Shen Zheng John executed a sale of 1,217 shares of common stock of Vicor CORP (NASDAQ:VICR) on March 4, 2026. The transaction price was $205.75 per share, producing total proceeds of $250,397. According to the filing, following the sale Shen holds no shares directly.

On that same date Shen also exercised options to acquire 1,217 shares of Vicor common stock at an exercise price of $32.89 per share, resulting in a notional value of $40,027 for the shares obtained through those options. The exercised awards are identified as Non Qualified Stock Options.

Market context reported alongside the filings notes that Vicor's stock has appreciated 233% over the prior year. At the time of the report the share price stood at $187.88, which is close to the 52-week high of $209.53 recorded for the company.

Valuation commentary included in the same report references InvestingPro's assessment that Vicor appears overvalued at current price levels, citing a price-to-earnings ratio of 73. The platform is also noted as offering 19 additional ProTips for investors evaluating VICR.


Summary of the transactions

  • Sale: 1,217 shares at $205.75 each on March 4, 2026, totaling $250,397; Shen holds no direct shares after the sale.
  • Option exercise: 1,217 shares acquired via Non Qualified Stock Options at $32.89 each on March 4, 2026, totaling $40,027.

Market snapshot provided in the filing

  • Shares up 233% over the past year.
  • Reported trading price at $187.88, near a 52-week high of $209.53.
  • InvestingPro flags a P/E ratio of 73 and lists 19 ProTips for VICR.

This account reflects the details contained in the filings and the accompanying valuation note. Where the provided material is limited, the reporting adheres strictly to the disclosed figures and statements.

Risks

  • InvestingPro describes Vicor as appearing overvalued with a P/E of 73, which raises valuation uncertainty for investors.
  • Following the sale, Shen no longer holds any shares directly, creating uncertainty about current insider direct ownership levels.
  • The stock is trading near its 52-week high, a factual position that can coincide with elevated market sensitivity to new information.

More from Insider Trading

Progressive Accounting Chief Disposes $55K in Stock as Shares Trade Near Yearly Low Mar 23, 2026 Old Second Bancorp Vice Chairman Disposes $429K in Shares; Ownership Stakes and Recent Results Also Detailed Mar 23, 2026 Vicor Chairman Disposes $7.9 Million in Stock; Transaction Executed Under 10b5-1 Plan Mar 23, 2026 Nutex Health President Buys $23,706 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026 Nutex Health Director Buys $14,033 in Stock as Q4 Revenue Slumps 41.1% Mar 23, 2026